雌激素受体向和孕激素受体向PET用于乳腺癌患者
Gary A Ulaner1, Amy M Fowler2, Amy S Clark3
1Molecular Imaging and Therapy, Hoag Family Cancer Institute, Newport Beach, CA, USA; Radiology and Translational Genomics, University of Southern California, Los Angeles, CA, USA.
16α-18F--17β-雌二醇 (18F-FES) PET成像被FDA批准用于ER阳性乳腺癌. 它有助于治疗选择,活检评估和评估不明确的病变,改善患者护理.
科学领域:
- 在瘤学瘤学.
- 核医学就是核医学.
- 放射性药物 放射性药物 放射性药物
背景情况:
- 雌激素受体 (ER) 阳性乳腺癌是一个重大的临床挑战.
- 准确评估ER状态对于指导内分泌治疗决策至关重要.
- 在某些乳腺癌病变中评估ER状态的传统方法存在局限性.
研究的目的:
- 为了突出16α-18F--17β- Estradiol (18F-FES) PET成像在ER阳性乳腺癌的临床实用性.
- 为了强调FDA对18F-FES PET的批准和已建立的应用.
- 简要地说,新兴的成像剂针对孕激素受体.
主要方法:
- 使用18F-FES作为一个向雌激素受体的正电子发射断层扫描 (PET) 追踪器.
- 在ER阳性乳腺癌患者的临床应用.
- 评估具有不确定的成像或活检结果的病变.
主要成果:
- 18F-FES PET已经证明了对ER阳性乳腺癌的多种经过验证的临床应用.
- 它有助于选择患者接受内分泌疗法.
- 它对于评估难以进行活检的病变中的ER状态和评估不确的成像发现有价值.
结论:
- 18F-FES PET成像是一种经过批准和有价值的工具,用于管理ER阳性乳腺癌.
- 它的应用包括指导治疗选择和改善具有挑战性的病例的诊断准确性.
- 目前正在进行的研究正在探索新的受体向成像剂.
更多相关视频
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
09:06Development of a 68Gallium-Labeled D-Peptide PET Tracer for Imaging Programmed Death-Ligand 1 Expression
Published on: February 3, 2023
相关概念视频
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
